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Introduction: Liquid sclerotherapy is a commonly performed procedure for treatment of varicose veins.
Neurological complications have been reported, however they are rare. Our case report highlights the
ﬁrst case of subarachnoid haemorrhage occurring post sclerotherapy.
Report: A previously healthy 63-year old lady presented with sudden onset headache and vomiting
immediately after injection of liquid sclerotherapy for lower limb varicose veins. Non-contrast CT brain
demonstrated acute subarachnoid haemorrhage. The patient was treated conservatively and made a full
recovery 48 h later.
Discussion: Subarachnoid haemorrhage occurring post sclerotherapy is a serious complication that is
associated with this procedure.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd.Open access under CC BY-NC-ND license. Case Report
A 63-year old lady presented to the ED with a short history of
sudden onset severe headache, vomiting and photophobia.
Several hours earlier, she underwent liquid sclerotherapy for
bilateral lower limb varicose veins. During the procedure, 17 ml of
0.5% liquid polidocanol (85mg) was injected into telangiectasia and
reticular veins. This volume is within the maximum recommended
dosage of 2 mg/kg as our patient weighed 68 kg. One month
previously, she had undergone bilateral long saphenous endove-
nous ablation procedure using VNUS (Covidien). This was followed
by one session of liquid sclerotherapy using 17 ml of 0.5% liquid
polidocanol which was uneventful. Her past medical and surgical
history includes hypothyroidism, hysterectomy and a caesarean
section. She was on aspirin and thyroxine.
During the procedure, the patient developed sudden onset
frontal headache. Her vital signs and neurological observations
remained normal during 2 h ofmonitoring. Her headache improved
and shewas given 1 g of paracetamol orally and discharged home. A
few hours later, her headache recurred, she developed nuchal pain
and vomited ﬁve times. She returned to the ED and was admitted.
An urgent neurosurgical opinion was sought and non-contrast
computed tomography (CT) of the brain was performed. ThisSurgery, Beaumont Hospital,
. Danapal).
gery. Published by Elsevier Ltd. Oprevealed evidence of subarachnoid haemorrhage (SAH) in the
supracellar cistern extending into the peri-sylvian area (Fig. 1).
Subsequent four vessel cerebral angiography and magnetic reso-
nance angiography (MRI) of the brain did not reveal any intracra-
nial aneurysm or any other intracranial vascular abnormalities. The
patient was treated conservatively with careful maintenance of
normothermia, normovolaemia and normal oxygenation. After 48 h
of neuro-observation the patient was discharged home. Her aspirin
was held for six weeks.
On a follow up visit the patient was doing well and had no
complications from the subarachnoid haemorrhage.
Discussion
Serious neurological complications occurring following foam
sclerotherapy have raised concerns regarding the safety of this
procedure. Four strokes have been reported to date with two of
them occurring directly after foam sclerotherapy.1e4 SAH post
sclerotherapy, however, has not been previously described. And no
strokes have previously been reported after liquid sclerotherapy, as
opposed to foam sclerotherapy.
SAH is an uncommon but frequently devastating condition.
There is a huge range in the age-adjusted annual incidence of SAH
between different countries ranging from 2.9 cases per 100,000 to
22.5 cases per 100,000.5 The incidence of SAH increases with age
and is more common in women. Multivariate studies have found
that hypertension, smoking, and heavy alcohol use to be indepen-
dent risk factors for SAH.6,7 SAH comprises between 1 and 7% of all
strokes and is a true medical emergency with 10e15% of patientsen access under CC BY-NC-ND license. 
Figure 1. Non-contrast CT brain demonstrates subarachnoid haemorrhage in the
supracellar cistern extending into the left peri-sylvian area.
M. Danapal et al. / EJVES Extra 23 (2012) e25ee26e26dying before they reach hospital. Intracranial aneurysms account
for 80% of spontaneous SAH (as opposed to traumatic SAH), 15% willhave no cause found and the remaining 5% will be caused by
various non-aneurysmal conditions such as arteriovenous malfor-
mations, coagulopathies, anticoagulants, intracranial tumours,
cocaine abuse and pituitary apoplexy.
Although the exact cause of SAH in this case is not certain, stress
and hypertension during sclerotherapy could potentially have
contributed. That being said, the patient’s blood pressure record-
ings were normal immediately on cessation of therapy and for 2 h
after the procedure.
Our case report brings to light an association between a poten-
tially fatal condition; subarachnoid haemorrhage and liquid poli-
docanol sclerotherapy, which is a widely used method for varicose
vein treatment. The occurrence of SAH during sclerotherapy
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